Jilin provincial vaccine lot release laboratory set up in China-ROK (Changchun) International Cooperation Demonstration Zone

2020-07-02

On June 30, the Jilin Provincial Institute for Drug Control and Jilin Yatai International Pharmaceutical Industrial Park Management Co Ltd signed a purchase agreement of vaccine lot release laboratory that is to enter the China-ROK (Changchun) International Cooperation Demonstration Zone, marking the full speed promotion of the construction of Jilin provincial vaccine lot release laboratory.

Jilin is a big province in vaccine production. At present, there are 6 vaccine production enterprises in the province, the number of which ranks top in the country. The live attenuated varicella vaccine produced in Jilin province is one of the domestically dominant products, and its released amount after approval accounts for over 60 percent of the whole country. The Jilin Provincial Institute for Drug Control is applying for port drug inspection agencies and building key laboratories for vaccine lot release and quality control of Chinese patent medicines to build an all-variety technical support system for the pharmaceutical and health industry.   
 
The construction of the vaccine lot release laboratory is a key project to ensure the safety of vaccines launched to the market, as well as an important measure to support the healthy development of Jilin pharmaceutical industry. The official launch of the vaccine lot release laboratory marks that the supervision of vaccines and other drugs in the province has entered a new period. After the completion of the laboratory, the life-cycle supervision and whole-chain service of drugs and vaccines are to be strengthened.
 
In addition, the Drug Safety Evaluation Center (GLP Laboratory) of Jilin Province has also landed in the China-ROK (Changchun) International Cooperation Demonstration Zone that is to provide technical support for pharmaceutical enterprises to research and develop new drugs.